ArticleAdvances in therapy2023

Biomarkers-Based Cost-Effectiveness of Toripalimab Plus Chemotherapy for Patients with Treatment-Naive Advanced Non-Small Cell Lung Cancer.

Huixian Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.